|
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2004;22(2): 138-144. |
Trichostatin A, a Histone Deacetylase Inhibitor, Potentiated Cytotoxic Effect of Ionizing Radiation in Human Head and Neck Cancer Cell Lines |
Jin Ho Kim, Jin Hee Shin, Eui Kyu Chie, Hong Gyun Wu, Jae Sung Kim, Il Han Kim, Sung Whan Ha, Charn Il Park, Wee Saing Kang |
1Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea. ihkim@snu.ac.kr 2Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. 3Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea. |
|
|
|
ABSTRACT |
PURPOSE: We have previously reported that human glioblastoma cells are sensitized to radiation-induced death after their exposure to trichostatin A (TSA), a histone deacetylase inhibitor (HDAC-I), prior to the irradiation. We aimed to measure the magnitude of the radiosensitizing effect of TSA in human head and neck cancer cell lines.
MATERIALS AND MEHTODS: Human head and neck cancer cell lines, HN-3 and HN-9, were exposed to 0, 50, 100, and 200 nM TSA for 18 hr prior to irradiation. Then, the TSA-treated cells were irradiated with 0, 2, 4, 6, and 8 Gy, and cell survival was measured by clonogenic assay.
RESULTS: Pre-irradiation exposure to TSA was found to radiosensitize HN-3 and HN-9 cell lines. In HN-9 cells, the fraction surviving after 2 Gy (SF2) was significantly reduced by treatment of TSA at concentration as low as 50 nM. However, a treatment with 200 nM TSA was required to significantly decrease SF2 in the HN-3 cell line. SER of pre-irradiation treatment with 200 nM TSA was 1.84 in HN-3 and 7.24 in HN-9, respectively.
CONCLUSIONS: Our results clearly showed that human head and neck cancer cell lines can be sensitized to ionizing radiation by pre-irradiation inhibition of histone deacetylase (HDAC) using TSA, and that this potentiation might well be a general phenomenon. |
Key Words:
Trichostatin A, Histone deacetylase inhibitor, Radiosensitization, Head and neck cancer |
|
|
|